Cargando…
Allergen-specific intralymphatic immunotherapy in human and animal studies
Clinical trials of intralymphatic immunotherapy (ILIT) have been performed to overcome the limitations of long-term therapy and the local or systemic hypersensitivity reactions in conventional allergen-specific immunotherapy, including subcutaneous or sublingual immunotherapy. Additionally, several...
Autores principales: | Kim, Seon Tae, Park, So Hyun, Lee, Sang Min, Lee, Sang Pyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537077/ https://www.ncbi.nlm.nih.gov/pubmed/28765817 http://dx.doi.org/10.5415/apallergy.2017.7.3.131 |
Ejemplares similares
-
Intralymphatic Immunotherapy Alleviates Allergic Symptoms During Allergen Exposure in Daily Life
por: Lee, Sang Pyo, et al.
Publicado: (2018) -
Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial
por: Park, Hye Jung, et al.
Publicado: (2021) -
Intralymphatic immunotherapy
por: Senti, Gabriela, et al.
Publicado: (2015) -
Intralymphatic Immunotherapy With Autologous Semen in a Korean Man With Post-Orgasmic Illness Syndrome
por: Kim, Tae Beom, et al.
Publicado: (2018) -
Mechanisms and biomarkers of successful allergen-specific immunotherapy
por: López, Juan-Felipe, et al.
Publicado: (2022)